Precision manufacturing for clinical-quality regenerative medicines. - Wikidata - wikimedia - TriplyDB

Precision manufacturing for clinical-quality regenerative medicines.

Precision manufacturing for clinical-quality regenerative medicines.

http://www.wikidata.org/entity/Q38026824

about

On the genealogy of tissue engineering and regenerative medicine Automated image analysis with the potential for process quality control applications in stem cell maintenance and differentiation Current status and perspectives on stem cell-based therapies undergoing clinical trials for regenerative medicine: case studies.Considerations for the clinical use of contrast agents for cellular MRI in regenerative medicine.Hollow fibre membrane bioreactors for tissue engineering applications.The early career researcher's toolkit: translating tissue engineering, regenerative medicine and cell therapy products.The translation of cell-based therapies: clinical landscape and manufacturing challenges.Growth Factor Content in Human Sera Affects the Isolation of Mesangiogenic Progenitor Cells (MPCs) from Human Bone Marrow.Developing an automated robotic factory for novel stem cell therapy production.Application of response surface methodology to maximize the productivity of scalable automated human embryonic stem cell manufacture.Visualizing medium and biodistribution in complex cell culture bioreactors using in vivo imaging.

P2860

Q28650026-72D28895-CB64-4F8E-B987-F81AD91F5523 Q28829627-68791D62-8ABC-41EE-B14E-B5693C5AE745 Q38160633-464579A0-D520-4427-AEF9-7AEE17229042 Q38174553-979D7B23-CB0B-401D-9547-A51F8975914B Q38234214-26B7E6DD-303F-4EC5-9272-A99DBB705C01 Q38656242-7309EBB9-70CE-4382-8593-3DCA4AEA531B Q39063831-1203DF4B-E93A-42B6-88F2-2B93668AB8D9 Q39228638-8395FD0D-9C32-4C1C-BA73-85B6BC1386C6 Q39775209-BD037E1C-C212-4EB6-9905-1E36A8098876 Q43543289-1F6193BF-882F-4499-B9F3-A126C043496D Q54569196-9D4B7E95-2E7B-49C1-9D67-77409ED89737

P2860

Precision manufacturing for clinical-quality regenerative medicines.

http://www.wikidata.org/entity/Q38026824

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Precision manufacturing for clinical-quality regenerative medicines.

@en

type

label

Precision manufacturing for clinical-quality regenerative medicines.

@en

prefLabel

Precision manufacturing for clinical-quality regenerative medicines.

@en

P1433

Q38026824-7DD66771-8430-46C5-9D3D-2C6253E08B2D

P1476

Q38026824-D1F4922B-756F-43A9-9258-4BCE0A64A754

P2093

Q38026824-3508251B-F5B9-4904-ADA0-3DBD639D7822

Q38026824-4D1F4DC0-F83F-4ACD-B569-5248E7D06982

Q38026824-A3C5CDA7-F047-4216-98D3-3FE210E19A5C

P2860

Q38026824-0061DA03-BC8E-4987-B8E2-0158E6B13EE5

Q38026824-0E9D7095-F865-461F-99AC-6BFEA3ECDF4E

Q38026824-0EF69B1B-CEBC-4980-BF25-BDF14AB4AC33

Q38026824-15AC74A0-CD3A-426D-8BAD-823B854D4822

Q38026824-1948C4E0-4FEF-46B1-BC32-27740C4B2538

Q38026824-1A911845-4B66-4848-95C0-F6BA6E590586

Q38026824-2EA47F44-858D-414F-A13D-35F05FF95689

Q38026824-37176461-A094-45D9-BA61-52BF1F7792AD

Q38026824-3D0CF50C-3B64-4D42-9188-A28BD5425B32

Q38026824-40EC99DA-1A11-4A6A-8CA6-CEB03E1DFB5F

P304

Q38026824-BD65B18C-B50A-44E7-B74C-BF2C119498D9

P31

Q38026824-391F28F0-CB4D-4677-8ABD-3F9D43C9A6D6

P356

Q38026824-E4156424-7993-4ED9-828C-7975BAE8F27A

P407

Q38026824-E6DE4D68-AC9E-40E4-A869-C9F3FA776048

P433

Q38026824-5E0BE68B-DD52-45D1-85B9-2D6ACD99E975

P478

Q38026824-BEAD5976-34B9-4E10-8E66-E085DED1205D

P50

Q38026824-2E30628D-91A4-4C66-B164-6AC59ABCC8DE

Q38026824-AA4E3167-8769-49DA-BB87-50DD08B27ED2

Q38026824-AD9EB306-27A1-42AD-BAFE-992692474251

Q38026824-C8BD728B-F33B-448F-A08B-649AE6C5351C

Q38026824-EC523ABB-DEF7-4E31-AE66-59AE7629AC6E

P577

Q38026824-32AD1003-3E1B-4A20-8FDC-393510BCD089

P5875

Q38026824-2CC04C43-8B35-42C9-A34F-3251BD23F214

P698

Q38026824-79346831-222B-4334-A559-BC507AA30B01

P356

P1433

Philosophical Transactions of the Royal Society A

P1476

Precision manufacturing for clinical-quality regenerative medicines

@en

P2093

David J Williams

http://www.w3.org/2001/XMLSchema#string

J Richard Archer

http://www.w3.org/2001/XMLSchema#string

Paul C Hourd

http://www.w3.org/2001/XMLSchema#string

P2860

The bioreactor: a powerful tool for large-scale culture of animal cells.

Manufacture of a human mesenchymal stem cell population using an automated cell culture platform.

Concise review: no breakthroughs for human mesenchymal and embryonic stem cell culture: conditioned medium, feeder layer, or feeder-free; medium with fetal calf serum, human serum, or enriched plasma; serum-free, serum replacement nonconditioned med

Future aspects of bioprocess monitoring.

Cell therapies: realizing the potential of this new dimension to medical therapeutics.

Controversial issue: is it safe to employ mesenchymal stem cells in cell-based therapies?

Optical spectroscopy for noninvasive monitoring of stem cell differentiation.

Three-dimensional culture and bioreactors for cellular therapies.

Current understanding and challenges in bioprocessing of stem cell-based therapies for regenerative medicine.

Automated, serum-free production of CTX0E03: a therapeutic clinical grade human neural stem cell line.

P304

3924-3949

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1098/RSTA.2011.0049

http://www.w3.org/2001/XMLSchema#string

P407

P433

1973

http://www.w3.org/2001/XMLSchema#string

P478

370

http://www.w3.org/2001/XMLSchema#string

P50

Elizabeth Ratcliffe

P577

2012-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

229156933

http://www.w3.org/2001/XMLSchema#string

P698

22802496

http://www.w3.org/2001/XMLSchema#string